Biotech developing treatments for gout and other metabolic and rare diseases.
Industry: Other
First Day Return: n/a
Industry: Other
IPO Data | |
---|---|
IPO File Date | 04/08/2014 |
Offer Price | $5.50 |
Price Range n/a | |
Offer Shares (mm) | 4.0 |
Deal Size ($mm) | $22 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 07/21/2014 |
Offer Price | IPO Intelligence Only |
Price Range | IPO Intelligence Only |
Offer Shares (mm) | IPO Intelligence Only |
Deal Size ($mm) | $22 |
Lock-Up Date | IPO Intelligence Only |
Street Research | IPO Intelligence Only |
Underwriters |
---|
IPO Intelligence Only |
Company Data | |
---|---|
Headquarters | Newark, CA, United States |
Founded | 1988 |
Employees at IPO | 15 |
Website www.cymabay.com |